4Q Loss: $1.6 billion (earnings were $411 million 4Q25) ...

AbbVie has submitted applications for a new indication for upadacitinib (RINVOQ) for the treatment of patients living with ...

Revenues up 7% in the quarter despite €801 million loss.

Braveheart Bio is naming Marc Evanchik Chief Scientific Officer (CSO) and appointing Brittany de Temple Senior Vice President ...

ADARx Pharmaceuticals has named Donald Fong, MD, its new Chief Medical Officer (CMO). He served in the same post at BioCryst Pharmaceuticals.

In 2026, some of the key industry trends essential to company success and maintaining stability include long-lasting ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

OXB and Bristol Myers Squibb (BMS) are expanding a partnership regarding manufacture and supply of lentiviral vectors for BMS ...

Charles River Laboratories will close its cell therapy contract development and manufacturing site in Hanover, Md., ...

Driven by the growing prevalence of chronic diseases, the need for convenient and cost-effective drug delivery solutions, and ...

Thermo Fisher Scientific will close a manufacturing facility in Franklin, Massachusetts, and eliminate up to 80 positions.

Acquired business specializes in lab-based research services using human tissue across preclinical and clinical settings.